AZENTA INC
AZTANASDAQTrading Snapshot
- Day Range
- $33.83 β $34.59
- 52-Week Range
- $15.93 β $41.73
- Volume
- $5.04B
- Avg Volume
- $4.38B
- Shares Outstanding
- 46.1M
- Next Earnings
- Nov 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $594M
- Last Q Revenue
- $161M
- P/E Ratio
- -12.4
- P/S Ratio
- 2.6x
- EPS (TTM)
- $-2.71
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.7%
Why Investors Own AZTA
- βHigh-growth profile β revenue up +19.0% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 15% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AZENTA INC
AZTAAbout AZENTA INC
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
AZENTA INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift AZTA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
AZENTA INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.